Cargando…

Using machine learning surrogate modeling for faster QSP VP cohort generation

Virtual patients (VPs) are widely used within quantitative systems pharmacology (QSP) modeling to explore the impact of variability and uncertainty on clinical responses. In one method of generating VPs, parameters are sampled randomly from a distribution, and possible VPs are accepted or rejected b...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Renée C., Augustin, Florian, Huard, Jérémy, Friedrich, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431055/
https://www.ncbi.nlm.nih.gov/pubmed/37328956
http://dx.doi.org/10.1002/psp4.12999
_version_ 1785091108456366080
author Myers, Renée C.
Augustin, Florian
Huard, Jérémy
Friedrich, Christina M.
author_facet Myers, Renée C.
Augustin, Florian
Huard, Jérémy
Friedrich, Christina M.
author_sort Myers, Renée C.
collection PubMed
description Virtual patients (VPs) are widely used within quantitative systems pharmacology (QSP) modeling to explore the impact of variability and uncertainty on clinical responses. In one method of generating VPs, parameters are sampled randomly from a distribution, and possible VPs are accepted or rejected based on constraints on model output behavior. This approach works but can be inefficient (i.e., the vast majority of model runs typically do not result in valid VPs). Machine learning surrogate models offer an opportunity to improve the efficiency of VP creation significantly. In this approach, surrogate models are trained using the full QSP model and subsequently used to rapidly pre‐screen for parameter combinations that result in feasible VPs. The overwhelming majority of parameter combinations pre‐vetted using the surrogate models result in valid VPs when tested in the original QSP model. This tutorial presents this novel workflow and demonstrates how a surrogate model software application can be used to select and optimize the surrogate models in a case study. We then discuss the relative efficiency of the methods and scalability of the proposed method.
format Online
Article
Text
id pubmed-10431055
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104310552023-08-17 Using machine learning surrogate modeling for faster QSP VP cohort generation Myers, Renée C. Augustin, Florian Huard, Jérémy Friedrich, Christina M. CPT Pharmacometrics Syst Pharmacol Tutorial Virtual patients (VPs) are widely used within quantitative systems pharmacology (QSP) modeling to explore the impact of variability and uncertainty on clinical responses. In one method of generating VPs, parameters are sampled randomly from a distribution, and possible VPs are accepted or rejected based on constraints on model output behavior. This approach works but can be inefficient (i.e., the vast majority of model runs typically do not result in valid VPs). Machine learning surrogate models offer an opportunity to improve the efficiency of VP creation significantly. In this approach, surrogate models are trained using the full QSP model and subsequently used to rapidly pre‐screen for parameter combinations that result in feasible VPs. The overwhelming majority of parameter combinations pre‐vetted using the surrogate models result in valid VPs when tested in the original QSP model. This tutorial presents this novel workflow and demonstrates how a surrogate model software application can be used to select and optimize the surrogate models in a case study. We then discuss the relative efficiency of the methods and scalability of the proposed method. John Wiley and Sons Inc. 2023-06-16 /pmc/articles/PMC10431055/ /pubmed/37328956 http://dx.doi.org/10.1002/psp4.12999 Text en © 2023 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Tutorial
Myers, Renée C.
Augustin, Florian
Huard, Jérémy
Friedrich, Christina M.
Using machine learning surrogate modeling for faster QSP VP cohort generation
title Using machine learning surrogate modeling for faster QSP VP cohort generation
title_full Using machine learning surrogate modeling for faster QSP VP cohort generation
title_fullStr Using machine learning surrogate modeling for faster QSP VP cohort generation
title_full_unstemmed Using machine learning surrogate modeling for faster QSP VP cohort generation
title_short Using machine learning surrogate modeling for faster QSP VP cohort generation
title_sort using machine learning surrogate modeling for faster qsp vp cohort generation
topic Tutorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431055/
https://www.ncbi.nlm.nih.gov/pubmed/37328956
http://dx.doi.org/10.1002/psp4.12999
work_keys_str_mv AT myersreneec usingmachinelearningsurrogatemodelingforfasterqspvpcohortgeneration
AT augustinflorian usingmachinelearningsurrogatemodelingforfasterqspvpcohortgeneration
AT huardjeremy usingmachinelearningsurrogatemodelingforfasterqspvpcohortgeneration
AT friedrichchristinam usingmachinelearningsurrogatemodelingforfasterqspvpcohortgeneration